Samsrita Labs Ltd — Updates, 23-05-2025: Company Update

Samsrita Labs Limited has announced a board meeting to alter its Memorandum of Association following shareholder approval. The authorized share capital has been increased from Rs. 16 Cr to Rs. 25 Cr, allowing for a higher equity base. Additionally, the company expanded its main business objects to include ventures in biofuels, food processing, green technologies, IT including deep tech, logistics, e-commerce, clinical research, advisory services, and investments. This broadening of scope signals strategic diversification beyond its core pharma operations, potentially opening new growth avenues for shareholders.